Canopy Growth (CGC) Cash & Current Investments (2017 - 2025)

Canopy Growth's (CGC) quarterly Cash & Current Investments came in at $148.7 million in Q4 2025, up 16.47% year-on-year from $127.7 million in Q4 2024, and up 51.46% quarter-over-quarter from $98.2 million in Q3 2025.

Canopy Growth (CGC) Cash & Current Investments (2017 - 2025) Analysis & Trends

Canopy Growth has disclosed Cash & Current Investments across 9 years of filings, most recently posting $148.7 million for Q4 2025.

  • Cash & Current Investments for Q4 2025 came in at $148.7 million, up 16.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $148.7 million (up 16.47% YoY), and the FY2025 annual result was $83.7 million, up 28.11% from the prior year.
  • Cash & Current Investments came in at $148.7 million for Q4 2025 at Canopy Growth, up from $98.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $954.6 million in Q2 2022 to a low of $12.7 million in Q2 2025.
  • The 5-year median for Cash & Current Investments is $306.2 million (2023), against an average of $372.5 million.
  • Across the five-year window, Cash & Current Investments jumped 104.37% in 2022 and sank 91.11% in 2025, its largest moves.
  • Canopy Growth's Cash & Current Investments stood at $497.7 million in 2021, then advanced by 16.83% to $581.4 million in 2022, then tumbled by 76.48% to $136.8 million in 2023, then slipped by 6.65% to $127.7 million in 2024, then rose by 16.47% to $148.7 million in 2025.
  • The last three Cash & Current Investments figures came in at $148.7 million (Q4 2025), $98.2 million (Q3 2025), and $12.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 2.15 Bn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 77.77 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 1.32 Bn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 511.86 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 498.58 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 750.88 Mn
10 Canopy Growth 11.27 Mn -137.42 Mn 15.39 Mn 148.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 148.69 Mn
Sep 30, 2025 98.18 Mn
Jun 30, 2025 12.67 Mn
Mar 31, 2025 83.69 Mn
Dec 31, 2024 127.67 Mn
Sep 30, 2024 172.93 Mn
Jun 30, 2024 142.52 Mn
Mar 31, 2024 65.33 Mn
Dec 31, 2023 136.76 Mn
Sep 30, 2023 187.20 Mn
Jun 30, 2023 425.13 Mn
Mar 31, 2023 571.95 Mn
Dec 31, 2022 581.44 Mn
Sep 30, 2022 582.01 Mn
Jun 30, 2022 954.63 Mn
Mar 31, 2022 622.28 Mn
Dec 31, 2021 497.70 Mn
Sep 30, 2021 651.29 Mn
Jun 30, 2021 467.11 Mn
Mar 31, 2021 921.24 Mn